AGN-190584

AbbVie claims first FDA okay for presbyopia drug therapy
Pharmaforum
Mon, 11/1/21 - 10:59 am
AbbVie
FDA
presbyopia
AGN-190584
Allergen builds case for first drug therapy for presbyopia
Pharmaforum
Mon, 07/26/21 - 09:35 am
Allergan
presbyopia
AGN-190584
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Wed, 10/28/20 - 10:50 am
Allergan
AbbVie
presbyopia
clinical trials
AGN-190584